Literature DB >> 28615442

The heterotrimeric G protein Gβ1 interacts with the catalytic subunit of protein phosphatase 1 and modulates G protein-coupled receptor signaling in platelets.

Subhashree Pradhan1,2, Tanvir Khatlani1,2, Angus C Nairn3, K Vinod Vijayan4,2,5,6.   

Abstract

Thrombosis is caused by the activation of platelets at the site of ruptured atherosclerotic plaques. This activation involves engagement of G protein-coupled receptors (GPCR) on platelets that promote their aggregation. Although it is known that protein kinases and phosphatases modulate GPCR signaling, how serine/threonine phosphatases integrate with G protein signaling pathways is less understood. Because the subcellular localization and substrate specificity of the catalytic subunit of protein phosphatase 1 (PP1c) is dictated by PP1c-interacting proteins, here we sought to identify new PP1c interactors. GPCRs signal via the canonical heterotrimeric Gα and Gβγ subunits. Using a yeast two-hybrid screen, we discovered an interaction between PP1cα and the heterotrimeric G protein Gβ1 subunit. Co-immunoprecipitation studies with epitope-tagged PP1c and Gβ1 revealed that Gβ1 interacts with the PP1c α, β, and γ1 isoforms. Purified PP1c bound to recombinant Gβ1-GST protein, and PP1c co-immunoprecipitated with Gβ1 in unstimulated platelets. Thrombin stimulation of platelets induced the dissociation of the PP1c-Gβ1 complex, which correlated with an association of PP1c with phospholipase C β3 (PLCβ3), along with a concomitant dephosphorylation of the inhibitory Ser1105 residue in PLCβ3. siRNA-mediated depletion of GNB1 (encoding Gβ1) in murine megakaryocytes reduced protease-activated receptor 4, activating peptide-induced soluble fibrinogen binding. Thrombin-induced aggregation was decreased in PP1cα-/- murine platelets and in human platelets treated with a small-molecule inhibitor of Gβγ. Finally, disruption of PP1c-Gβ1 complexes with myristoylated Gβ1 peptides containing the PP1c binding site moderately decreased thrombin-induced human platelet aggregation. These findings suggest that Gβ1 protein enlists PP1c to modulate GPCR signaling in platelets.

Entities:  

Keywords:  ADP; G protein-coupled receptor (GPCR); megakaryocytes; phosphoprotein phosphatase 1 (PP1); platelet; protein phosphatase 1; thrombin

Mesh:

Substances:

Year:  2017        PMID: 28615442      PMCID: PMC5555177          DOI: 10.1074/jbc.M117.796656

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Rapid dephosphorylation of G protein-coupled receptors by protein phosphatase 1β is required for termination of β-arrestin-dependent signaling.

Authors:  Florian Pöll; Christian Doll; Stefan Schulz
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 2.  The PP1 binding code: a molecular-lego strategy that governs specificity.

Authors:  Ewald Heroes; Bart Lesage; Janina Görnemann; Monique Beullens; Luc Van Meervelt; Mathieu Bollen
Journal:  FEBS J       Date:  2012-03-21       Impact factor: 5.542

3.  A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling.

Authors:  Peisong Ma; Aleksandra Cierniewska; Rachel Signarvic; Marcin Cieslak; Hong Kong; Andrew J Sinnamon; Richard R Neubig; Debra K Newman; Timothy J Stalker; Lawrence F Brass
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

4.  Decreased expression of phospholipase C-beta 2 isozyme in human platelets with impaired function.

Authors:  S B Lee; A K Rao; K H Lee; X Yang; Y S Bae; S G Rhee
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

5.  Regulation of IκB kinase by GβL through recruitment of the protein phosphatases.

Authors:  Dong-Joo You; You Lim Kim; Cho Rong Park; Dong-Kyu Kim; Jeonghun Yeom; Cheolju Lee; Curie Ahn; Jae Young Seong; Jong-Ik Hwang
Journal:  Mol Cells       Date:  2010-11-23       Impact factor: 5.034

6.  Protein phosphatase 2A negatively regulates integrin alpha(IIb)beta(3) signaling.

Authors:  Francisca C Gushiken; Vimal Patel; Yan Liu; Subhashree Pradhan; Angela L Bergeron; Yuandong Peng; K Vinod Vijayan
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

7.  Phosphorylation of serine 1105 by protein kinase A inhibits phospholipase Cbeta3 stimulation by Galphaq.

Authors:  C Yue; K L Dodge; G Weber; B M Sanborn
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

Review 8.  Protein phosphatase 1--targeted in many directions.

Authors:  Patricia T W Cohen
Journal:  J Cell Sci       Date:  2002-01-15       Impact factor: 5.285

9.  Development of a peptide that selectively activates protein phosphatase-1 in living cells.

Authors:  Jayanta Chatterjee; Monique Beullens; Rasa Sukackaite; Junbin Qian; Bart Lesage; Darren J Hart; Mathieu Bollen; Maja Köhn
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-07       Impact factor: 15.336

10.  Cyclic nucleotide dependent dephosphorylation of regulator of G-protein signaling 18 in human platelets.

Authors:  Kristina Gegenbauer; Zoltan Nagy; Albert Smolenski
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

View more
  4 in total

1.  C-Peptide Inhibits Decidualization in Human Endometrial Stromal Cells via GSK3β-PP1.

Authors:  Sana Abdul Khaliq; Mi-Ock Baek; Hye-Jeong Cho; Seung Joo Chon; Mee-Sup Yoon
Journal:  Front Cell Dev Biol       Date:  2020-11-30

Review 2.  Nanomaterial-Based Therapy for Wound Healing.

Authors:  Anamika Kushwaha; Lalit Goswami; Beom Soo Kim
Journal:  Nanomaterials (Basel)       Date:  2022-02-12       Impact factor: 5.076

Review 3.  Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries.

Authors:  Álvaro Sierra-Sánchez; Kevin H Kim; Gonzalo Blasco-Morente; Salvador Arias-Santiago
Journal:  NPJ Regen Med       Date:  2021-06-17

4.  Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc.

Authors:  Yingqiu Liu; Tianyi Liu; Kevin Ding; Zengyuan Liu; Yuanyuan Li; Taotao He; Weimin Zhang; Yunpeng Fan; Wuren Ma; Li Cui; Xiaoping Song
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.